About 400 reports

  • MARKET SEGMENTS
  • GLOBAL STD TESTING MARKET: YEAR-OVER-YEAR (YOY) GROWTH 2018-2022 (%)

However, it is used in laboratories as automated instruments, which quantify properties of cells, one cell at a time.

  • Sexually Transmitted Disease
  • World
  • bioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • BY CONSUMABLES AND ACCESSORIES
  • BY LOCATION OF TESTING

If one' s sexual history and current signs and symptoms suggest that one has an STI, laboratory tests can identify the cause and detect coinfections one might have contracted.

  • Sexually Transmitted Disease
  • World
  • Market Size
  • F. Hoffmann-La Roche Ltd.
  • Inc. Hologic, Inc.

Hoffmann-La Roche Ltd. - Key offerings Exhibit ##: Validation techniques employed for market sizing Exhibit ##: Definition of market positioning of vendors Companies Mentioned • Abbott Laboratories • bioMérieux SA • Bio-Rad Laboratories Inc. • Danaher Corp. • F.

  • Pathology
  • Sexually Transmitted Disease
  • World
  • Forecast

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Not Applicable Companies Mentioned - Hologic Inc - Qiagen NV - Roche Diagnostics Corp - Abbott Laboratories - Biocare Medical LLC - Enzo Life Sciences Inc - Leica Microsystems GmbH - Thermo

  • Sexually Transmitted Disease
  • World
  • Demand
  • Forecast
  • Supply

The company constantly engages in R& D activities at its California-based Westridge Laboratories.

  • Sexually Transmitted Disease
  • Europe
  • World
  • Market Size
  • Reckitt Benckiser Group plc

Symptoms can be mild or acute from one individual to another.

  • Infectious Disease
  • Pathology
  • Sexually Transmitted Disease
  • World
  • Market Shares
  • Key vendor analysis
  • Introduction

The Tier ## companies are providing a one-stop solution to the customers (end-users: Hospitals, clinics and laboratories, and physician office laboratories) to increase the market growth.

  • Sexually Transmitted Disease
  • Abbott Laboratories, Inc.
  • Hologic, Inc.
  • QIAGEN N.V.
  • Roche Group

Key strategic moves and developments List of Tables TABLE ##.

  • Pathology
  • Sexually Transmitted Disease
  • Market Size
  • SYPHILIS TESTING MARKET IN EMEA 2017-2022 ($ MILLIONS)
  • Vendor classification

You can easily book an appointment with one online.

  • Sexually Transmitted Disease
  • World
  • Forecast
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.

Founded in 1989, Trigg Laboratories based out of Las Vegas, Nevada, US.

  • Sexual Wellness
  • Sexually Transmitted Disease
  • World
  • Market Size
  • Reckitt Benckiser Group plc
  • SWOT Analysis of Qiagen in the HPV & EBV Tests, 2017
  • Mergers and Acquisitions, HPV & EBV Tests

The country' s health sector is a mixed one.

  • In Vitro Diagnostic Reagent
  • Sexually Transmitted Disease
  • Hologic, Inc.
  • QIAGEN N.V.
  • Roche Group
  • RISING GOVERNMENT INITIATIVES TO COMBAT ANTIBIOTIC RESISTANCE

For instance, in 1986, the CDC collaborated with the local STD clinics and their laboratories in the US.

  • Sexually Transmitted Disease
  • World
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

You can easily book an appointment with one online.

  • Diagnostics
  • Hospital
  • Sexually Transmitted Disease
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.

You can easily book an appointment with one online.

  • Sexually Transmitted Disease
  • United States
  • Abbott Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Roche Group

Scale = ## to ##, where ## is low impact & ## is high impact.

  • Contraceptive
  • OTC
  • Sexually Transmitted Disease
  • World
  • Market Size

THE COMPANY CONSTANTLY ENGAGES IN R& D ACTIVITIES AT ITS CALIFORNIA-BASED WESTRIDGE LABORATORIES.

  • Sexually Transmitted Disease
  • North America
  • United States
  • World
  • Market Size
  • Germany - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • 9.1.2 HPV DNA Test Population

Since 2008, all laboratories are required to report complete data sets to local quality control agencies.

  • Sexually Transmitted Disease
  • Southeast Asia
  • Western Europe
  • World
  • Forecast

MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japa

  • Sexually Transmitted Disease
  • Europe
  • Japan
  • United States
  • Demand

MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japa

  • Sexually Transmitted Disease
  • Europe
  • Japan
  • United States
  • Demand

Mayer Laboratories, Inc.

  • Pathology
  • Sexually Transmitted Disease
  • United States
  • Forecast

MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japa

  • Sexually Transmitted Disease
  • Europe
  • Japan
  • United States
  • Demand

MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japa

  • Sexually Transmitted Disease
  • Europe
  • Japan
  • United States
  • Demand

MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japa

  • Pathology
  • Sexually Transmitted Disease
  • World
  • Demand

MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japa

  • Pathology
  • Sexually Transmitted Disease
  • World
  • Demand
  • Market Shares

MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japa

  • Sexually Transmitted Disease
  • Europe
  • Japan
  • United States
  • Demand
  • 11.1.2 Germany Cervical Cancer HPV DNA Test Population & Forecast

Since 2008, all laboratories are required to report complete data sets to local quality control agencies.

  • Cancer Diagnostics
  • Cervical Cancer
  • Genetic Testing
  • Sexually Transmitted Disease
  • Forecast

MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japa

  • Sexually Transmitted Disease
  • Europe
  • Japan
  • United States
  • Demand

MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japa

  • Pathology
  • Sexually Transmitted Disease
  • World
  • Demand
  • Market Shares

MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japa

  • Sexually Transmitted Disease
  • Europe
  • Japan
  • United States
  • Demand

MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U. S., five major European countries and Japa

  • Sexually Transmitted Disease
  • Europe
  • Japan
  • United States
  • Demand